Sanofi-Synthelabo
Pharmaceuticals
France
France
| Current Rank | 360 |
| Prior Rank | N/A |
| Executive 1 | J.-f. Dehecq, Chairman, Board of Directors |
| Executive 2 | H. Guerin, Vive-Chairman & Chief Executive Officer |
| Revenue (US$ Millions) | $5,387 |
| Revenue Growth (%) | 20.89% |
| Net Income (US$ Millions) | $629 |
| Earnings Per Share (US$) | $0.86 |
| Total Equity (US$ Millions) | $3,603 |
| Profit Margin (%) | 11.68% |
| Debt To Equity Ratio (%) | 0.27% |